Higher Age Puts Lung Cancer Patients at Risk for Not Receiving Anti-cancer Treatment
- Author:
Won Il CHOI
1
;
Jiah CHOI
;
Mi Ae KIM
;
Gyumin LEE
;
Jihyeon JEONG
;
Choong Won LEE
Author Information
- Publication Type:Original Article
- Keywords: Lung neoplasms; Age; Treatment
- MeSH: Diagnosis; Drug Therapy; Humans; Logistic Models; Lung Neoplasms; Lung; Medicaid; Myocardial Infarction; National Health Programs; Primary Health Care; Referral and Consultation; Renal Insufficiency, Chronic
- From:Cancer Research and Treatment 2019;51(3):1241-1248
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: We aimed to determine the demographic and epidemiologic variables that are associated with no treatment in lung cancer patients. MATERIALS AND METHODS: Patient data were collected from the Korean National Health Insurance Database. The lung cancer group included patients with an initial diagnosis of lung cancer between January 2009 and December 2014. Treated cases were defined as those that underwent surgery, radiation, or chemotherapy until death, after the diagnosis of lung cancer. Risk of no treatment was calculated by multiple logistic regression analysis. RESULTS: Among the 2,148 new cases of lung cancer from 2009 to 2104, 612 (28.4%) were not treated. Risk of no treatment was higher in the following patients: patients in their 60s (odds ratio [OR], 1.18; 95% confidence interval [CI], 0.75 to 1.84), 70s (OR, 3.64; 95% CI, 2.41 to 5.50), and >80 years old (OR, 16.55; 95% CI, 10.53 to 25.03) than those in their 50s; patients with previous myocardial infarction (OR, 2.07; 95% CI, 1.01 to 4.25) or chronic kidney disease (OR, 2.88; 95% CI, 1.57 to 5.30); and patients diagnosed at a non-referral hospital (OR, 1.40; 95% CI, 1.01 to 1.92) or primary care provider (OR, 1.81; 95% CI, 1.43 to 2.29) compared with referral hospital. Low-income patients receiving Medicaid were 1.75 times (95% CI, 1.14 to 2.68) more likely to forgo treatment than high-income patients (upper 20%). Risk was not associated with sex or the year in which the lung cancer was diagnosed. CONCLUSION: Age predominantly determines whether patients with lung cancer undergo anti-cancer treatment.
